Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates
about
Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer researchImaging the DNA damage response with PET and SPECTIBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.Low dose IR-induced IGF-1-sCLU expression: a p53-repressed expression cascade that interferes with TGFβ1 signaling to confer a pro-survival bystander effect.DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of Radiosensitivity.Gamma-H2AX upregulation caused by Wip1 deficiency increases depression-related cellular senescence in hippocampus.Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.DNA double-strand break repair: a theoretical framework and its application.Molecular and cellular effects of Auger emitters: 2008-2011.Engineered antibodies for molecular imaging of cancer.Imaging the inside of a tumour: a review of radionuclide imaging and theranostics targeting intracellular epitopes.Uptake, internalization and nuclear translocation of radioimmunotherapeutic agents.PET imaging of DNA damage using (89)Zr-labelled anti-γH2AX-TAT immunoconjugates.Harnessing Integrative Omics to Facilitate Molecular Imaging of the Human Epidermal Growth Factor Receptor Family for Precision Medicine.γH2AX expression in cytological specimens as a biomarker of response to radiotherapy in solid malignancies.Inhibition of the HDAC/Suv39/G9a pathway restores the expression of DNA damage-dependent major histocompatibility complex class I-related chain A and B in cancer cellsThe Future of Radiobiology.Downregulation of B-myb promotes senescence via the ROS-mediated p53/p21 pathway, in vascular endothelial cells.Preclinical Optimization of Antibody-based Radiopharmaceuticals for Cancer Imaging and Radionuclide Therapy - Model, Vector, and Radionuclide Selection.Subcellular Targeting of Theranostic Radionuclides
P2860
Q27023686-A1AE999E-7E0E-43BA-BC42-CEE73748E1FFQ33581909-6C2AA2A2-2E04-4BCB-A52B-95E5064C35BEQ35992493-7BC108B6-F954-43D4-B6A0-BAB64B2DBB28Q36019718-8768B740-277D-475E-A21A-62CD9CD37585Q36073749-54DEB44E-8292-4D21-AA5F-E34D4F7E86A0Q36148914-19D7582E-591E-429F-846B-8F2FFF525E86Q36525188-CBCA7BC4-6230-4229-92BE-4C17C0CA6C83Q36596145-BE6AAFCC-B85E-40C1-AEFE-2398451A3B14Q38018374-4F52ABF5-A594-4F75-A3A4-8DBEDBE9C33DQ38148881-60345222-C8F8-4A3F-BED3-13338CF45601Q38176263-6852F4ED-8CAB-4936-82B7-A66E175DF121Q38193173-C59FD065-7D1A-4F21-8BEE-F65FC3396C0DQ38868860-1D556664-3057-433A-8595-24C18B57D891Q39389369-3E737E37-4FA0-45BF-855D-552313504772Q42588714-5D698555-4ED2-4803-B0FE-DB939B392A75Q42835134-C42927F7-C833-4808-8DBD-D9C2ECE803D8Q46136392-4AB442E7-4293-4135-AB3F-9DE5693BF8BCQ46455601-F07A1306-8A4D-4F94-A650-D386B3DE3B43Q48089417-FC069C8C-331B-4C08-B425-AD053584B517Q58764832-2E052673-434B-4F6C-A182-351D8201FE6B
P2860
Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates
@ast
Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates
@en
type
label
Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates
@ast
Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates
@en
prefLabel
Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates
@ast
Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates
@en
P2093
P2860
P50
P1433
P1476
Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates
@en
P2093
James Thompson
Kate Sleeth
Ketan Shah
Mark A Hill
Sonali Darbar
P2860
P304
P356
10.1158/0008-5472.CAN-10-4587
P407
P577
2011-05-17T00:00:00Z